Pay in 4 interest-free payments of $30.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Uridine triphosphate treatment induces Schwannoma cell migration through activation of P2Y2 receptors and through the increase of extracellular matrix metalloproteinase-2 (MMP-2) activation and expression
InChiKey: HWSHOMMVLGBIDN-UHFFFAOYSA-N
C2HF3O2/c1-32(2)23-36(66)54(95)76-37(14-17-51(91)92)57(98)77-38(15-18-52(93)94)58(99)80-42(30-83)56(97)72-26-47(87)69-25-46(86)70-28-49(89)74-41(24-33(3)4)59(100)81-53(34(5)6)62(103)79-40(13-16-45(67)85)63(104)82-21-10-12-44(82)61(102)73-27-48(88)71-29-50(90)75-43(31-84)60(101)78-39(19-22-107-7)55(96)68-20-9-8-11-35(65)64(105)106
partially selective protein cross-linking may represent an alternate approach to affect signal transduction modules and ubiquitin cycle-regulatory proteins for cancer therapy
sparsely scattered Aβ deposits are visible
3-O-Acetyl Ezetimibe-d4 Size:Contact [email protected] for quotation Uridine triphosphate treatment induces SchwannomaProduct information CAS Number: 1217642 08 4 Molecular Weight: 455. 49 Formula: C26H23F2NO4 Chemical Name: (1S) 3 [(2S,3R) 1 [4 fluoro(2,3,5,6 H)phenyl] 2 (4 hydroxyphenyl) 4 oxoazetidin 3 yl] 1 (4 fluorophenyl)propyl acetate Smiles: [2H]C1=C(C([2H])=C([2H])C(F)=C1[2H])N1[C@@H]([C@@H](CC[C@H](OC(C)=O)C2C=CC(F)=CC=2)C1=O)C1C=CC(O)=CC=1 InChiKey: HFQRXXWTCQBULQ RXBMDDDJSA N InChi: InChI=1S C26H23F2NO4 c1 16(30)33 24(17 2 6 19(27)7 3 17)15 14 23 25(18 4